| 发明名称 |
Heterocyclic amides as RIP1 kinase inhibitors as medicaments |
| 摘要 |
Disclosed is a method of treating a RIP1 kinase-mediated disease or disorder which comprises administering a therapeutically effective amount of a compound that inhibits RIP1 kinase and at least one other therapeutically active agent to a patient in need thereof. |
| 申请公布号 |
AU2015304851(A1) |
申请公布日期 |
2017.02.23 |
| 申请号 |
AU20150304851 |
申请日期 |
2015.08.20 |
| 申请人 |
GlaxoSmithKline Intellectual Property Development Limited |
发明人 |
Berger, Scott B.;Gough, Peter J.;Weisel, Kathleen M. |
| 分类号 |
A61K31/55;A61K31/551;A61K31/5513;A61K31/553;A61K31/554;A61K45/06;A61P17/06;A61P25/28;A61P29/00;A61P37/00;A61P43/00 |
主分类号 |
A61K31/55 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
